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Constitutive albumin uptake by the proximal tubule is
achieved by a receptor-mediated process in which the
Cl channel, ClC-5, plays an obligate role. Here we in-
vestigated the functional interaction between ClC-5 and
ubiquitin ligases Nedd4 and Nedd4-2 and their role in
albumin uptake in opossum kidney proximal tubule
(OK) cells. In vivo immunoprecipitation using an anti-
HECT antibody demonstrated that ClC-5 bound to ubiq-
uitin ligases, whereas glutathione S-transferase pull-
downs confirmed that the C terminus of ClC-5 bound
both Nedd4 and Nedd4-2. Nedd4-2 alone was able to alter
ClC-5 currents in Xenopus oocytes by decreasing cell
surface expression of ClC-5. In OK cells, a physiological
concentration of albumin (10 g/ml) rapidly increased
cell surface expression of ClC-5, which was also accom-
panied by the ubiquitination of ClC-5. Albumin uptake
was reduced by inhibiting either the lysosome or pro-
teasome. Total levels of Nedd4-2 and proteasome activ-
ity also increased rapidly in response to albumin. Over-
expression of ligase defective Nedd4-2 or knockdown of
endogenous Nedd4-2 with small interfering RNA re-
sulted in significant decreases in albumin uptake. In
contrast, pathophysiological concentrations of albumin
(100 and 1000 g/ml) reduced the levels of ClC-5 and
Nedd4-2 and the activity of the proteasome to the levels
seen in the absence of albumin. These data demonstrate
that normal constitutive uptake of albumin by the prox-
imal tubule requires Nedd4-2, which may act via ubiq-
uitination to shunt ClC-5 into the endocytic pathway.
One of the major roles of the renal proximal tubule is to
constitutively reabsorb proteins such as albumin that are fil-
tered across the glomerulus (1). In humans, the kidneys filter
180 liters of blood per day. The concentration of albumin in
the glomerular filtrate in humans has recently been estimated
to be 3.5 mg/liter, within the range measured in rodents and
dogs (1–50 mg/liter) (2). This translates into at least 600 mg
of albumin crossing the glomerular barrier in humans each
day, yet less than 30 mg is normally excreted in the urine per
day (3), with the rest reabsorbed by the proximal tubule (1).
The linear sequence of events by which this is accomplished is
characteristic of receptor-mediated endocytosis: (i) albumin
acts as a ligand for the megalin-cubulin scavenger receptor; (ii)
after binding, the albumin-receptor complex is internalized
into clathrin-coated pits; (iii) as the early endosome progresses
to a late endosome, the intraendosomal fluid is acidified, and
the albumin dissociates from the receptor complex; and (iv) the
albumin is degraded in the lysosome to its constituent amino
acids (1, 4). The exact molecular mechanisms, however, and the
protein-protein interactions that mediate this highly active
endocytotic apparatus remain largely unresolved. It is now
apparent that a macromolecular complex is required for effi-
cient uptake of albumin (5). This complex includes the albumin
receptor, megalin-cubulin, as well as several plasma mem-
brane ion transporters/channels; v-type H-ATPase, Na-H
exchanger isoform 3 (NHE3),1 and the Cl channel ClC-5 (6).
Each of these proteins has specific ion transporting functions
with key roles in regulating the ionic composition of the vesicle
during endosomal formation and acidification (6–8). More re-
cently, it has been recognized that these proteins may have
roles additional to their ion transporting activity. These involve
macromolecular complex assembly and the recruitment of var-
ious signaling molecules, mediated by interactions of the intra-
cellular carboxyl termini with diverse cytosolic proteins. Exam-
ples of this include PDZ-mediated interactions between NHE3
and the cytoskeleton and other transporters/receptors (9–11),
megalin interacting with G-interacting protein (12), and
ClC-5 interacting with cofilin (5).
One of the most pronounced examples of defective albumin
uptake due to a genetic disorder is observed in Dent’s disease.
In this disease, patients present with persistent low molecular
weight proteinuria and microalbuminuria (13). Dent’s disease
is due to mutations in ClC-5 that disrupt its trafficking/func-
tion (8) with similar increases in urinary protein excretion
observed in ClC-5 knock-out mice models (14, 15). In both
cases, the increased protein in the urine is due to defective
endocytosis in the proximal tubule. These findings point to an
obligate role for ClC-5 in albumin uptake. Initially, the reduc-
tion in albumin uptake was thought to be due to ClC-5 failing
to act as an anion shunt to neutralize v-type H-ATPase-
mediated H movement during endosomal acidification (16).
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More recently, however, it has been shown that in Dent’s dis-
ease, defects in ClC-5 also result in mistrafficking of both
megalin and v-type H-ATPase (17, 18). Furthermore, we have
demonstrated that ClC-5 interacts with cofilin to modulate the
actin cytoskeleton in the local vicinity of the endocytic complex
(5). These findings highlight the importance of understanding
the mechanisms that underlie the trafficking of ClC-5, because
the availability of ClC-5 at the plasma membrane could be
predicted to be a rate-limiting factor in albumin uptake by the
proximal tubule.
One mechanism for regulating cell surface levels of mem-
brane proteins is ubiquitination by WW-HECT ubiquitin-pro-
tein ligases, such as Nedd4, Nedd4-2, and WWP2, which typi-
cally results in ubiquitination of the target protein leading to
its removal from the membrane and degradation in protea-
somes (19). These ligases have been shown to regulate surface
expression and activity of epithelial Na channels in native
cells (20–23), and a much wider range of channels and trans-
porters has been observed to be regulated in this way in the
Xenopus oocyte expression system, including the voltage-gated
K channel Kv1.3 (24), the voltage-gated Na channel SCN5A
(25), other neuronal voltage-gated Na (Nav) channels (26), the
Na phosphate transporter NaPi IIb (27), the glutamate trans-
porter EAAT1 (28), and the glutamine transporter SN1 (29) as
well as the Cl channel ClC-2 (30). The plasma membrane
levels of ClC-5 have also been shown to be regulated by WWP2
in Xenopus oocytes (28). This then raises the question as to
whether WWP2, or perhaps Nedd4/4-2, are physiological regu-
lators of ClC-5 in vivo and whether they regulate only the
surface levels of the channel itself or also ClC-5-dependent
albumin endocytosis by the proximal tubule. The aim of the
current study was therefore to determine whether Nedd4/4-2
has a role in constitutive albumin uptake in a cell culture
model of the proximal tubule.
EXPERIMENTAL PROCEDURES
Cell Cultures—The opossum kidney (OK) cell line was obtained from
Dr. D. Markovich (University of Queensland, Australia). Cells were
maintained in Dulbecco’s modified Eagle’s medium/Ham’s F-12 medium
supplemented with 10% fetal bovine serum, 1% penicillin, and strepto-
mycin and incubated at 37 °C in 5% CO2. For all experiments, OK cells
were seeded to confluence and grown for 5 days to allow the formation
of a polarized monolayer. The cells were then incubated for 2 days in 5
mM glucose Dulbecco’s modified Eagle’s medium/F-12 medium under
serum-free conditions.
Immunoprecipitation with Anti-HECT Antibody—An antibody that
recognizes the HECT domains of Nedd4 and Nedd4-2 (31) was used to
isolate proteins from OK cell lysate. Briefly, OK cells were lysed in lysis
buffer containing 50 mM Tris-HCl, 150 mM NaCl, 1% Triton X-100 (pH
7.5), and Complete Protease inhibitors (Roche Applied Science). Protein
A-agarose (5 l; Roche Applied Science) was incubated with the lysate
for 3 h at 4 °C. The precleared lysate was then incubated with anti-
HECT or control antibodies at 4 °C overnight. Protein A-agarose (50 l)
was again added to the sample, which was incubated for 3 h at 4 °C. The
pelleted beads were washed three times in 500 l of wash buffer (50 mM
Tris-HCl, 500 mM NaCl, 0.1% Triton X-100, pH 7.5), and the samples
were eluted into Laemmli gel sample buffer, separated on a 5% SDS-
PAGE gel, and then transferred to nitrocellulose membranes. The blot
was probed with anti-ClC-5 antibody as described previously (5).
GST Pull-down Assay—The carboxyl terminus of ClC-5 (residue
Arg563 to the stop codon at position 747) was cloned into the EcoRI and
XhoI sites on the vector pGEX-6P-1 (Amersham Biosciences). The GST
fusion protein, GST-ClC-5-ct, was produced using the GST purification
module (Amersham Biosciences) as previously described (5). For the
pull-down assay, GST or GST-ClC-5-ct fusion protein (50 g) was incu-
bated with glutathione-Sepharose 4B beads (Amersham Biosciences)
for 3 h at 4 °C. The beads were then washed by centrifugation and
incubated with the Triton X-100-soluble fraction (1 mg) from OK cells at
4 °C for 18 h. The beads were then washed, and the samples were eluted
into Laemmli gel sample buffer, separated on a 10% SDS-PAGE gel,
and transferred to nitrocellulose membranes. The Western blots were
probed with anti-Nedd4 and anti-Nedd4-2 primary antibodies and sec-
ondary horseradish peroxidase-conjugated antibodies and detected
with SuperSignal West Pico substrate (Pierce).
Xenopus Oocyte Expression of ClC-5 and Nedd4/Nedd4-2—Capped
RNA transcripts encoding full-length human ClC-5, ClC-5 containing a
Y672A mutation (ClC-5 PY mut), Nedd-4, Nedd4-2, or the ligase-defec-
tive cysteine to serine mutants of Nedd4 and Nedd4-2 (Nedd4/Nedd4-2
Cys mut) were synthesized using a mMESSAGE mMachine in vitro
transcription kit (Ambion). Xenopus laevis stage V-VI oocytes were
removed and treated with collagenase (Sigma Type I) for defollicula-
tion. The oocytes were then injected with the cRNA of the ClC-5 channel
(2.5 ng/oocyte) with or without the Nedd4 or Nedd4-2 cRNAs (10 ng/
oocyte). The oocytes were incubated at 18 °C in ND96 solution (96 mM
NaCl, 2 mM KCl, 1 mM CaCl2, 1 mM MgCl2, 5 mM HEPES, 5 mM pyruvic
acid, and 50 g/ml gentamicin, pH 7.5) prior to recording. Three days
after cRNA injection, whole cell Cl channel currents were recorded
from oocytes using the two-electrode (virtual ground circuit) voltage
clamp technique. Microelectrodes were filled with 3 M KCl and typically
had resistances of 0.3–1.5 megaohms. All recordings were made at room
temperature (20–23 °C) using a bath solution containing the following
components: 100 mM NaCl, 2 mM KCl, 1 mM MgCl2, 0.3 mM CaCl2, 20
mM Hepes, pH 7.5, with NaOH. During recording, oocytes were per-
fused continuously at a rate of 1.5 ml/min. Using a GeneClamp 500B
amplifier and pCLAMP 8 software (Axon Instruments Inc, Union City,
CA), data were low pass-filtered at 1 kHz, digitized at 10 kHz, and
leak-subtracted on-line using a P/6 protocol and analyzed off-line.
Inward Cl currents were generated by holding the cells at70 mV and
applying step depolarizations to membrane potentials from 30 mV to
80 mV.
Surface expression of ClC-5 was determined by the method of Zer-
angue et al. (32). Oocytes were injected with the following RNA at 10
ng/oocyte: HA-tagged ClC-5 (a kind gift of Prof. Thomas Jentsch) with
or without Nedd4-2/Nedd4-2 Cys mut and, as a negative control, ClC-5
without the HA tag. After 2–3 days at 18 °C, oocytes were placed in
ND96 with 1% BSA to block unspecific binding and then incubated for
60 min with a rat monoclonal anti-HA antibody (1 g/ml; 3F10; Roche
Molecular Biochemicals) in 1% BSA/ND96, washed for 60 min with 1%
BSA/ND96, and incubated with horseradish peroxidase-coupled second-
ary antibody (goat anti-mouse conjugated to horseradish peroxidase
(Pierce)) in 1% BSA/ND96 for 60 min. Oocytes were washed as previ-
ously and transferred to frog Ringer solution (82.5 mM NaCl, 2 mM KCl,
1 mM MgCl2, 5 mM HEPES, pH 7.5) without BSA. All incubations and
washes were performed at 4 °C. Individual oocytes were placed in 50 l
of Supersignal Elisa Femto maximum sensitivity substrate solution
(Pierce) and incubated at room temperature for 5 min. Chemilumines-
cence was quantified using a Fluostar Optima microplate reader
(BMG Technologies).
In Vivo Ubiquitination of ClC-5—Either HA-tagged ubiquitin (HA-
Ub) (33) or His-tagged ubiquitin (His-Ub) (34) was transiently trans-
fected into OK cells. Confluent monolayers were incubated in albumin
(10 g/ml) and/or carbobenzoxy-L-leucyl-L-leucyl-L-leucinal (MG-132) (6
M) for 3 h at 37 °C. Triton X-100-soluble fractions were obtained as
described above. For cells expressing the HA-Ub, immunoprecipitation
to detected ubiquitinated proteins was performed using the HA anti-
body (Roche) as described above, except that the wash solution lacked
detergent. For cells expressing His-Ub, the ubiquitinated proteins were
isolated using the method of Staub et al. (35). Briefly, cells were lysed
in 100 mM HEPES, 150 mM NaCl, 1.5 mM MgCl2, 1 mM EDTA, 1%
Triton X-100, 10% glycerol, and 6 M MG-132, and the cell lysate was
incubated with Ni2-nitrilotriacetic acid-agarose beads (Qiagen) at 4 °C
for 4 h. The beads were washed two times with 20 mM HEPES, pH 7.5,
300 mM NaCl, 0.1% Triton X-100, 10% glycerol and three times in lysis
solution. In each case, bound proteins were eluted into Laemmli sample
buffer and separated on a 5% SDS-PAGE, transferred to nitrocellulose,
and immunoblotted with anti-ClC-5 antibody as described previously
(5).
Cell Surface Expression of ClC-5—Cell surface proteins were bioti-
nylated using the method of Lisanti et al. (36). Briefly, confluent OK cell
monolayers were exposed to albumin (10 g/ml) and/or MG-32 (6 M) for
3 h at 37 °C. Monolayers were washed three times in cold phosphate-
buffered saline and then biotinylated with 1.22 mg/ml EZ-Link NHS-
SS-Biotin (Pierce) at 4 °C with gentle agitation. Monolayers were
washed three times in cold phosphate-buffered saline, and the cells
were lysed as described previously. The biotinylated proteins were
isolated by binding to ImmunoPure immobilized Streptavidin (Pierce)
for 15 min on ice. The beads were pelleted, and the supernatant that
contained the cytosolic (unbiotinylated) fraction was recovered by cen-
trifugation at 4500  g for 6 min at 4 °C. The membrane (biotinylated)
fraction was washed, and the pellet was suspended in Laemmli sample
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buffer. Equal protein amounts of the cytosolic and of the biotinylated
fraction were resolved on a 5% SDS-polyacrylamide gel and transferred
to nitrocellulose, and Western blot was performed with the anti-ClC-5
antibody as previously described (5).
Albumin Uptake—Albumin uptake was measured using a modifica-
tion of standard method as previously described (5, 37, 38). Confluent
monolayers were grown in 48-well plates and treated with the different
experimental conditions. Cells pretreated with MG-132 (6 M) and/or
chloroquinine (CHQ) (100 M) were incubated for 1 h at 37 °C. OK cells
were transiently transfected with Nedd4 (31) and Nedd4-2 (39) and
Nedd4 and Nedd4-2 Cys mut. In addition, cells were transiently trans-
fected with pSuper (40) containing a sequence for siRNA for the
Nedd4-2 (AAGTGGTTGACTCCAACGACT) (pSuperNedd4-2). In trans-
fection experiments, the cells were transfected with the cDNA plasmids
or mock-transfected with empty vector (control) and then grown for 7
days before experimentation. Transfection of the plasmid was per-
formed following the manufacturer’s protocol with Effectene (Qiagen),
for the Nedd4/Nedd4-2 constructs and Fugene (Roche Applied Science)
for the Nedd4-2 siRNA. To measure albumin uptake, the treated cells
were exposed to 50 g/ml of albumin conjugated to Texas Red (TR-
albumin) (Molecular Probes) for 120 min. Nonspecific binding was de-
termined in cells exposed to albumin for 1 min. Receptor-mediated
albumin uptake is effectively abolished by disruption of the actin cy-
toskeleton (5, 37), with total TR-albumin uptake being reduced to less
than 80% of control values in the presence of latrunculin A or cytocha-
lasin B. The residual (20%) component represents nonspecific albu-
min uptake mechanisms present in all cell types (e.g. fluid phase up-
take). In the current study, we defined receptor-mediated TR-albumin
uptake as that component of albumin uptake that is sensitive to inhi-
bition of actin polymerization by latrunculin A. At the end of the uptake
period, cells were washed in HEPES buffer, pH 6, at 4 °C and then
solubilized in MOPS lysis buffer (20 mM MOPS, 0.1% Triton X-100, pH
7.4). The TR-albumin fluorescence was determined using a Fluostar
Optima microplate reader (BMG Technologies) at 580-nm excitation
and 630-nm emission wavelengths. Total TR-albumin uptake was stan-
dardized to total cellular protein, and the amount of fluorescence per g
of cellular protein was then adjusted for the latrunculin A-insensitive
component.
Proteasome Activity Assay—Proteasomal activity in OK cells was
determined using the method of Kirkpatrick et al. (41). Cells were
incubated with albumin (10, 100, or 1000 g/ml) for 2 h. Cells were
lysed in 0.1% Triton X-100/phosphate-buffered saline, and 250-g ali-
quots of the lysates were added to 75 M N-succinyl-Leu-Leu-Val-Tyr-
7-amino-4-methylcoumarin (LLVY-AMC) to a final volume of 100 l.
The reaction mixture was incubated at 30 °C for 1 h, and the fluores-
cence intensities were measured in a Fluostar Optima plate reader with
wavelengths of 360-nm excitation and 460-nm emission. Background
fluorescence, consisting of the reaction mixture incubated at 30 °C for 1
min, was subtracted from the fluorescence values. Data are presented
as percentage of control (100%), cells not treated with albumin.
Materials—The generation of the polyclonal antibodies has been
described previously: anti-ClC-5 (5) (kindly provided by Prof. Olivier
Devuyst, Division of Nephrology, Universite´ Catholique de Louvain
Medical School, Belgium) and anti-HECT (31) and anti-Nedd4-2 (42).
Anti-Nedd4 antibody was kindly provided by Dr. Daniela Rotin (The
Hospital for Sick Children, University of Toronto, Canada). The HA-
tagged ClC-5 in the Xenopus expression vector was kindly provided by
Prof. Thomas Jentsch (Centre for Molecular Neurobiology, Hamburg
University, Germany). The His-tagged ubiquitin was provided by Prof.
Ron Kopito (Department of Biological Sciences, Stanford University,
Stanford, CA). CHQ was obtained from Sigma, MG-132 was from Cal-
biochem, and LLVY-AMC was from Biomol. Secondary antibodies con-
jugated to horseradish peroxidase were from Pierce.
Quantification of Results and Statistical Analysis—Densitometric
analysis of the Western blot data was performed using Fujifilm Sci-
enceLab 99 Image Gauge (version 3.3). Statistical analyses of the data
were performed using analysis of variance and Dunnett’s Multiple
Comparison Test or Student’s t test (oocyte data). A p value of less than
0.05 was considered significant.
RESULTS
In Vitro Interaction between ClC-5 and Nedd4/Nedd4-2—
Both Nedd4 and Nedd4-2 are ubiquitin ligases that contain
HECT domains; therefore, in order to determine whether ClC-5
interacted with these HECT domains, we first performed a
co-immunoprecipitation in OK cell lysate using an antibody
that cross-reacts with both Nedd4 and Nedd4-2 HECT do-
mains. The subsequent Western blots clearly demonstrated
that there was a physical interaction between ClC-5 and a
HECT domain (Fig. 1A). We then performed a series of pull-
down experiments with GST-ClC-5-ct to determine whether
Nedd4 or Nedd4-2 interacted with ClC-5 in an in vitro system.
GST-ClC-5-ct bound to glutathione-Sepharose beads was incu-
bated with OK cell lysate, and the proteins bound to the beads
FIG. 1. In vivo and in vitro binding
of ClC-5 to ubiquitin ligases. A, immu-
noprecipitation using anti-HECT anti-
body and cell lysate from OK cells indi-
cates that ClC-5 binds to HECT domain-
containing ubiquitin ligases. B, OK cell
lysates were incubated with GST or GST-
ClC-5-ct fusion protein, and Western blot
analysis were performed. Nedd4, Nedd4
binds to GST-ClC-5-ct and not GST alone.
Nedd4-2, Nedd4-2 binds to GST-ClC-5-ct
and not GST alone. Representative blots
from three separate experiments are
shown.
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were eluted and then Western blotted and probed with anti-
bodies against either Nedd4 or Nedd4-2. In the presence of
GST-ClC-5-ct, both Nedd4 (120 kDa) and Nedd4-2 (115
kDa) were detected (Fig. 1B). The doublets observed were prob-
ably due to splice variants (43, 44). In contrast, in control
samples incubated with GST alone, no bands for Nedd4 or
Nedd4-2 were observed. These data confirmed that OK cells did
contain both Nedd4 and Nedd4-2 and that the C terminus of
ClC-5 interacted with both of these proteins.
Nedd4/Nedd4-2 and ClC-5 Channel Activity—The Xenopus
expression system was used to investigate whether Nedd4/
Nedd4-2 had any effect on the whole-cell currents mediated by
ClC-5. Xenopus oocytes were co-injected with the cRNA for
ClC-5 and wild type or Nedd4/Nedd4-2 Cys mut and standard
two-electrode voltage clamp used to determine the whole-cell
currents. In oocytes injected with ClC-5 cRNA alone, we ob-
served strongly rectifying Cl currents that started between
10 to 20 mV, characteristic of ClC-5 (Fig. 2, A and B). These
currents were not observed in control uninjected oocytes and
furthermore, these currents were reduced in the presence of
iodide, an anion that has a lower conductance through ClC-5
(data not shown). When either Nedd4 or Nedd4 Cys mut was
co-expressed with ClC-5, there were no significant effects on
the magnitude of the ClC-5 currents. However, in oocytes over-
expressing Nedd4-2, there was a significant reduction in whole-
cell currents measured at50 mV to 72.4 3.13% (n 19; p
0.0001) of control values (Fig. 2). Increasing the amount of
Nedd4-2 cRNA injected per oocyte to 50 ng resulted in a further
reduction to 54.9  5.8% (n  19; p  0.0001) of controls. This
value was significantly less (p  0.01) than the value obtained
at 10 ng of Nedd4-2. In contrast, overexpression of the Nedd4-2
Cys mut (10 ng/oocyte) resulted in a pronounced increase in
whole-cell currents to 145.8  7.3% (n  20; p  0.0001) of
control values. The magnitude of this effect was not altered in
oocytes injected with 50 ng of cRNA (139.4  8.1%; n  11; p 
0.0001). These data clearly demonstrated a specific and func-
tional interaction between Nedd4-2 and ClC-5 and pointed to a
specific role for Nedd4-2 in regulating the magnitude of ClC-5
currents.
Nedd4/Nedd4-2 typically bind a PY motif in the C terminus
of plasma membrane proteins, and mutations in this motif
result in a loss of Nedd4/Nedd4-2 binding (34, 39). We therefore
used ClC-5 PY mut and repeated the above oocyte experiments.
In oocytes injected with ClC-5 PY mut, the Cl currents in-
creased to the same levels (142.5  7.2%; n  15; p  0.0001)
as those in oocytes co-expressing wild type ClC-5 with Nedd4-2
FIG. 2. Effects of Nedd4/Nedd4-2 on
ClC-5 currents in Xenopus oocytes. A,
representative current traces from oo-
cytes expressing ClC-5 alone, ClC-5 plus
Nedd4-2, ClC-5 plus Nedd4-2 Cys mut, or
ClC-5 PY mut. B, current-voltage rela-
tionships for oocytes expressing ClC-5
with the various Nedd4/Nedd4-2 con-
structs or ClC-5 PY mut expressed alone.
Individual points represent the mean 
S.E. of 15–20 oocytes from three or four
separate batches. C, bar graphs showing
the percentage changes in the Cl current
amplitude at 50 mV relative to the con-
trol (I/Io) (oocytes expressing only ClC-5).
ClC-5 was co-expressed in oocytes with
the various Nedd4/Nedd4-2 constructs, or
ClC-5 PY mut was expressed alone. Data
are expressed as the mean  S.E. of
15–20 oocytes from three or four separate
batches.
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Cys mut. Furthermore, when the ClC-5 PY mut was co-ex-
pressed with either wild type Nedd4/Nedd4-2 or Nedd4/
Nedd4-2 Cys mut, the currents remained elevated above the
controls. This clearly indicated that abolition of the PY domain
prevented any effect of Nedd4-2 on ClC-5. The increases in
ClC-5 currents under these conditions suggested constitutive
endogenous Nedd4/Nedd4-2 activity in oocytes that influenced
the surface levels of ClC-5. Overexpression of Nedd4-2 Cys mut
overrode this effect, resulting in ClC-5 currents that were iden-
tical in magnitude to those observed in oocytes expressing the
ClC-5 PY mut.
The above data were consistent with the decrease in ClC-5
currents in response to Nedd4-2 due to a reduction in the
number of ClC-5 channels at the cell surface. We confirmed this
hypothesis using a luminescence-based cell surface assay and a
ClC-5 channel expressing an extracellular HA-epitope (HA-
ClC-5) (19). Oocytes were coinjected with the mRNA for the
HA-ClC-5 with or without Nedd4-2 or Nedd4-2 Cys mut, and
the surface HA-ClC-5 was detected in a luminometer using a
luciferase secondary antibody system. Results were calculated
as relative light units per oocyte standardized to HA-ClC-5
(Fig. 3). Control oocytes expressing HA-ClC-5 had a strong
signal (n  42; standardized to 100 4.3%). Coexpression with
Nedd4-2 reduced surface levels of HA-ClC-5 to 72.4  4.8% of
control levels (n  40; p  0.001). In contrast, coexpression
with Nedd4-2 Cys mut resulted in an increase in the cell
surface levels of HA-ClC-5 to 193.8  11.2% compared with
control (n  35; p  0.0001). In oocytes expressing a nontagged
ClC-5, there was almost no background signal detected (2.2 
0.7% of control (n  40; p  0.0001)). The data were obtained
from oocytes from three separate batches with at least 12
oocytes per group analyzed in each experiment. These experi-
ments clearly demonstrated that the Nedd4-2-mediated
changes in ClC-5 currents were due to changes in cell surface
levels of the channel.
Effects of Albumin on Total ClC-5 Levels—Given that ClC-5
has an obligate role in albumin uptake, it is possible that the
cells may autoregulate the levels of ClC-5 to maintain constant
levels during albumin uptake. This may involve up-regulation
of the total levels of ClC-5 to cope with the increased levels of
endocytosis in the presence of albumin. In control cells not
exposed to albumin, there was no significant effect on the levels
of ClC-5 following treatment with the proteasomal inhibitor
MG-132 (Fig. 4A). However, in parallel experiments in cells
exposed to albumin (10 g/ml) for 3 h, there was a significant
increase in the levels of ClC-5 to 150  6% (n  4; p  0.001)
of the levels in the absence of albumin. Proteasome inhibition
in the presence of albumin further increased in ClC-5 levels to
218  22% of control levels (n  4; p  0.001), a level signifi-
cantly greater with albumin alone (p  0.01; Fig. 4B), indicat-
ing that the proteasome also plays a role in regulating levels of
ClC-5. Thus, the presence of normal tubular levels of albumin
results in a rapid elevation in the levels of total ClC-5 protein,
presumably reflecting an increased requirement for ClC-5 upon
initiation of albumin uptake.
Cell Surface Biotinylation—The above data were consistent
with physiological levels of albumin leading to increased ClC-5
at the plasma membrane in order to initiate albumin endocy-
tosis. We therefore used cell surface biotinylation to determine
any changes in the surface levels of ClC-5 in response to albu-
min. Each experimental protocol was repeated three times on
separate batches of cells. Representative blots and results are
shown in Fig. 4. In control cells (not exposed to albumin), there
was a detectable level of ClC-5 in the plasma membrane (Fig. 4,
C and D). Under these conditions, inhibition of the proteasome
with MG132 resulted in a significant increase in the surface
levels of ClC-5, most likely due to the known effect of protea-
some inhibition on endocytosis and recycling (45, 46). Impor-
tantly, exposure to albumin (10 g/ml) for 3 h caused a signif-
icant increase in the amount of ClC-5 at the cell surface to
554  95% (n  3; p  0.01) of control levels (Fig. 4, C and D),
consistent with the increase in total ClC-5 observed in response
to albumin (Fig. 4A). Inhibition of the proteasome in the pres-
ence of albumin caused a further small but significant (p 
0.05) increase in the cell surface levels of ClC-5 above those
observed in the presence of albumin. In contrast, no significant
changes were observed in the levels of cytosolic ClC-5, indicat-
ing that the increase in total ClC-5 in response to albumin is
primarily due to increased ClC-5 in the membrane fraction.
Ubiquitination of ClC-5—Removal of a plasma membrane
protein by Nedd4-2 is generally associated with polyubiquiti-
nation of that protein. We used different methods to determine
the ubiquitination status of ClC-5 in the presence of albumin.
OK cells transfected with either HA-Ub or His-Ub were ex-
posed to albumin and MG-132. The HA-tagged samples were
immunoprecipitated using anti-HA antibody, whereas the His-
tagged samples were harvested using Ni2-nitrilotriacetic acid
beads. In both cases, the bound proteins were eluted and run on
Western blots and probed with an antibody against ClC-5.
Each experimental protocol was repeated three times on sepa-
rate batches of cells. Representative results are shown in Fig.
5, A and B. Under control conditions (no albumin), there were
no bands visible for ClC-5 and only very faint bands in the
presence of MG-132. In cells incubated with albumin, there was
a faint band for ClC-5 in the cells expressing the HA-Ub. In
contrast, in cells exposed to albumin and MG-132, there were
large single bands for both HA- and His-Ub. These data clearly
show that ClC-5 is ubiquitinated in the presence of albumin,
but this species is short lived, since it can only be detected
under conditions in which the normal albumin uptake pathway
is disrupted with MG-132.
FIG. 3.Cell surface expression of ClC-5 is regulated by Nedd4-2
in Xenopus oocytes. Surface expression of HA-tagged ClC-5 in the
absence and presence of Nedd4-2 or Nedd4-2 Cys mut. Surface levels of
HA-ClC-5 were measured using an antibody-based chemiluminescence
assay. Oocytes injected with ClC-5 without a HA tag were used as a
negative control. Results are expressed in relative light units (RLU) per
oocyte, normalized to HA-tagged ClC-5 expressed alone. Data are ex-
pressed as mean  S.E. of 40 oocytes from 12 batches (*, p  0.001
relative to control).
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Degradation Pathways and Albumin Uptake—The monou-
biquitination of ClC-5 in the presence of albumin suggested
that the channel was being shunted into the endocytic/lyso-
some pathway as a result of albumin uptake. Blocking the
lysosomes with CHQ reduced TR-albumin uptake to 60  7%
(n  3; p  0.05) of control levels (Fig. 6). Similarly, inhibiting
the proteasome with MG-132 reduced TR-albumin uptake to
59  6% (n  3; p  0.05) of control levels (Fig. 6). Treatment
FIG. 4. ClC-5 protein levels in re-
sponse to albumin and proteasomal
inhibition. A, representative Western
blots for ClC-5 in cell lysates from OK
cells under control conditions or exposed
to albumin (10 g/ml) for 2 h with or
without pretreatment with the protea-
some inhibitor MG-132 (6 M). B, densi-
tometric analysis of ClC-5 protein levels.
Inhibition of the proteasome has no effect
on the control levels of ClC-5. Albumin (10
g/ml) induces a significant increase in
the levels of ClC-5, which is further in-
creased by proteasomal inhibition. Data
are expressed as mean  S.E. of four sep-
arate experiments. *, p 0.001 relative to
control; , p  0.01 relative to albumin
alone. C, representative Western blots for
ClC-5 in cell lysates from OK cells under
control conditions or exposed to albumin
(10 g/ml) for 2 h with or without pre-
treatment with the proteasome inhibitor
MG-132 (6 M) and fractionated into cell
surface (biotinylated) and cytoplasmic
(nonbiotinylated) fractions. D, densito-
metric analysis of ClC-5 protein levels in
cell surface (black) and cytoplasm (gray).
Inhibition of the proteasome and treat-
ment with albumin increases the levels of
ClC-5 at the cell surface compared with
control levels of ClC-5 (*, p  0.001 rela-
tive to control).
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of cells with both MG-132 and CHQ further reduced TR-albu-
min uptake to 29  6% (n  3; p  0.05) of the control levels,
a level significantly lower than that observed for either treat-
ment alone, suggestive of an additive effect (Fig. 6). These
experiments demonstrated that both the lysosomal and protea-
somal pathways are required for efficient albumin processing
by OK cells.
Nedd4/Nedd4-2 and Albumin Uptake—The data in the oo-
cytes showed that the cell surface levels of ClC-5 could be
regulated by Nedd4-2 and could hence represent a rate-limiting
step in albumin uptake. We therefore investigated the effects of
Nedd4 and Nedd4-2 overexpression or suppression on albumin
uptake. OK cells were transfected with wild type Nedd4 or
Nedd4-2 or the Cys mutants. Overexpression of wild type
Nedd4 or Nedd4-2 or Nedd4 Cys mut had no significant effects
on TR-albumin uptake (Fig. 7A). In contrast, overexpression of
the Nedd4-2 Cys mut reduced TR-albumin uptake to 67  7%
(n  3; p  0.05) of control levels. It is important to note, as we
have previously published (5), that the transfection efficiency of
the OK cells under these conditions is of the order of 50–60%;
therefore, the 33% reduction we observe in TR-albumin up-
take in the total population of cells significantly underesti-
mates the true reduction in TR-albumin uptake in cells over-
expressing Nedd4-2 Cys mut.
Since overexpression strategies may alter the expression of
other proteins, we then used a silencing RNA approach to
confirm the specificity of the role of Nedd4-2 in regulating
albumin uptake. Cells were transiently transfected with pSu-
per control plasmid or pSuperNedd4-2. We first investigated
whether this siRNA specifically suppressed Nedd4-2 in OK
cells. Cells were transiently transfected and Western blots for
Nedd4 and Nedd4-2 performed on Triton X-100-soluble frac-
tions. The presence of the siRNA caused a pronounced reduc-
tion in the levels of Nedd4-2 to 30  9% (n  3; p  0.01) of
control, cells transfected with pSuper alone, whereas the levels
of Nedd4 remained unchanged (Fig. 7B). The large effect of the
siRNA in these Western blot experiments reflects a higher
expression efficiency of the siRNA driven by a promiscuous
promoter, such that even cells that only contain only a minimal
amount of the plasmid DNA still produce enough silencing
RNA to knock down the levels of Nedd4-2. We then measured
albumin uptake in cells expressing pSuperNedd4-2 and found
that TR-albumin uptake was significantly reduced to 72  2%
(n 4; p 0.0001) of control levels (Fig. 7C). These data clearly
show that Nedd4-2 is a specific physiological regulator of con-
stitutive albumin uptake in OK cells.
Proteasome Activity—The previous experiments suggested a
role for the proteasome in regulating albumin uptake. We
therefore investigated the effects of albumin on the activity of
the proteasome itself. We used a fluorescent proteasome sub-
strate (LLVY-AMC) to directly measure proteasomal activity in
OK cells. Exposure to albumin (10 g/ml) for 2 h significantly
increased proteasomal activity with LLVY-AMC fluorescence
increasing to 171  25% (n  4; p  0.01) of control levels (Fig.
8). We repeated the experiments in the presence of higher
concentrations of albumin. Interestingly, as the concentration
of albumin increased, proteasome activity progressively de-
creased, such that at 1000 g/ml albumin, the activity was only
131 18% (n 4; p 0.01) of control, a value significantly less
than that observed with 10 g/ml albumin (Fig. 8).
Protein Levels of Nedd4 and Nedd4-2—Elevated levels of
ubiquitin ligases have been reported in chronic disease states
such as muscle wasting (47). We used Western blotting to
investigate whether albumin uptake was associated with any
acute changes in the protein levels of ClC-5 and Nedd4/
Nedd4-2 upon activation of the albumin uptake pathway.
Exposure to albumin (10 g/ml) for 2 h resulted in a rapid
and pronounced increase in the levels of Nedd4-2 protein to
187  8% (n  3; p  0.001) of control levels (Fig. 9, A and B).
This effect was exclusive for Nedd4-2, since no change in the
level of Nedd4 was observed under these conditions. Al-
though the levels of Nedd4-2 remained elevated at higher
concentrations (100 g/ml) of albumin (163  13%; n  3;
p  0.05), there was a reversal toward control levels, with the
level at 1000 g/ml albumin being significantly lower than
that observed at 10 g/ml albumin (131 5%; n 3; p 0.01,
FIG. 5.ClC-5 is ubiquitinated in the presence of albumin. A, OK
cells were transiently transfected with His-Ub and the ubiquitinated
proteins isolated using Ni2-nitrilotriacetic acid-agarose beads follow-
ing exposure to albumin (10 g/ml) and/or MG-132 (6 M) for 3 h. B, OK
cells were transiently transfected with HA-Ub, and the ubiquitinated
proteins were isolated by immunoprecipitation using anti-HA antibody
following exposure to albumin (10 g/ml) and or MG-132 (6 M) for 3 h.
These data suggest that ClC-5 was rapidly ubiquitinated in the pres-
ence of albumin.
FIG. 6. Effect of lysosomal and pro-
teasomal inhibition on the uptake of
albumin. OK cells were pretreated with
either CHQ (100 M) or MG-132 (6 M),
and the uptake of TR-albumin was deter-
mined. Combined exposure to both chlo-
roquinine and MG-132 caused a signifi-
cantly greater inhibition than either
treatment alone. Data are expressed as
mean  S.E. of three separate experi-
ments. *, p  0.01 relative to control; **,
p  0.05 relative to either inhibitor alone.
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Fig. 9, C and D). Similarly, exposure of cells to 10 g/ml
albumin caused a pronounced increase in the levels of ClC-5
(206  20%; n  3, Fig. 9, C and D). This increase persisted
in cells exposed to 100 g/ml albumin (158  29%, Fig. 9, C
and D). However, when the cells were exposed to 1000 g/ml
albumin, the levels of ClC-5 protein returned to control levels
(Fig. 9, C and D). This reduction in ClC-5 protein at 1000
g/ml albumin was significantly different from that in cells
exposed to 10 g/ml albumin (n  3, p  0.01).
DISCUSSION
ClC-5 appears to play an obligate role in facilitating albumin
uptake by the proximal tubule at least at two levels. First, it is
involved in formation of the endocytic complex (5, 15), and
FIG. 7. Role of Nedd4/Nedd4-2 in albumin uptake. A, TR-albumin uptake was measured in OK cells transiently transfected with either
Nedd4/Nedd4-2 or Nedd4/Nedd4-2 Cys mut. Data are expressed as mean  S.E. of three separate experiments (*, p  0.05 relative to pCDNA3
control; , p  0.05 relative to Nedd4 Cys mut). B, representative Western blot for Nedd4/Nedd4-2 in cell lysates of OK cells transfected with
pSuper or the Nedd4-2 siRNA construct pSuperNedd4-2. Nedd4-2 was strongly suppressed, whereas there was no effect on endogenous Nedd4
levels. C, TR-albumin uptake in OK cells transiently transfected with pSuper or pSuperNedd4-2. Data are expressed as mean  S.E. of three
separate experiments (*, p  0.001).
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second, it plays an important role as an anion shunt during the
acidification of the endosomes (16). Therefore, the cell surface
availability of ClC-5 could be predicted to be a rate-limiting
step in albumin uptake, and ClC-5 must be routed into the
albumin degradative pathway. Physiological levels of albumin
appear to trigger an endocytic pathway that involves a signif-
icant increase in the turnover of plasma membrane compo-
nents and presumably up-regulation of the proteins involved.
This is supported by studies from our group and others that
show that albumin causes an increase in the protein levels and
activity of NHE3 (48, 49). The molecular mechanisms that
govern the assembly of the albumin endocytic complex and how
surface levels of ClC-5 are maintained remain largely unclear
but are likely to involve C-terminal interactions between the
various proteins within the complex and other cytosolic regu-
lators. The current study further characterizes the molecular
changes that take place in OK cells to enable constitutive
albumin uptake in response to physiological levels of albumin.
FIG. 8. Proteasomal activity in response to albumin. OK cells
were exposed to increasing concentrations of albumin for 2 h, and then
the relative fluorescence intensity of the proteasomal substrate LLVY-
AMC was determined. Data are expressed as mean  S.E. of three
separate experiments (*, p  0.01 relative to control; , p  0.05; 1000
g/ml albumin relative to 10 g/ml albumin).
FIG. 9. Acute effects of albumin on
cellular levels of Nedd4/Nedd4-2 and
ClC-5. A, representative Western blots of
lysates from OK cells exposed to albumin
(10 g/ml) for 2 h. Blots were probed with
antibodies directed against either Nedd4
or Nedd4-2. B, densitometric analysis of
Nedd4/Nedd4-2 levels in lysates from OK
cells exposed to albumin (10 g/ml). Data
are expressed as mean  S.E. of three
separate experiments (*, p  0.001). C,
representative Western blot of Nedd4-2
and ClC-5 levels in lysates from OK cells
exposed to increasing concentrations of
albumin. D, densitometric analysis of
Nedd4-2 (black) and ClC-5 (gray) levels in
lysates from OK cells exposed to increas-
ing concentrations of albumin. Data are
expressed as mean  S.E. of three sepa-
rate experiments (*, p  0.01 relative to
control; , p  0.05 relative to 10 g/ml
albumin).
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In this paper, we demonstrate protein-protein interactions be-
tween the C terminus of ClC-5 and the ubiquitin ligases Nedd4/
Nedd4-2 and that Nedd4-2 is a physiological regulator of con-
stitutive albumin uptake by cells of proximal tubule origin. We
also show that albumin increases both the total amount of
ClC-5 and the levels of ClC-5 at the plasma membrane and that
ClC-5 is ubiquitinated, providing a mechanism to route ClC-5
into the endocytic pathway.
Using in vitro techniques, we showed that ClC-5 interacted
with both Nedd4 and Nedd4-2. In Xenopus oocytes, however,
we found that overexpression of Nedd4-2 maximally reduced
ClC-5-mediated currents and cell surface expression of ClC-5
by50%, whereas Nedd4 had no effect. This contrasts with the
regulation of ENaC and Nav1.2 and Nav1.7 in Xenopus oocytes,
where maximal levels of Nedd4-2 almost completely abolish
ENaC currents, whereas Nedd4 only partially inhibits the cur-
rents (21, 26, 33, 50, 51). The reasons for the differential
efficacy of Nedd4-2 in Xenopus oocytes on ENaC, Nav, and
ClC-5 currents remain unresolved. It is possible that this re-
flects the need for an adaptor protein that is not present in
oocytes in concentrations sufficient to optimize Nedd4-2 actions
on ClC-5 or, alternatively, another E3 ubiquitin ligase being
the endogenous effector in oocytes.
The observation that Nedd4-2 acts on ClC-5 via the C-termi-
nal PY motif is consistent with the previously observed action
of the WW domains of WWP2 (19). Similarly, the effect of the
Nedd4-2 Cys mut in increasing ClC-5 currents is comparable
with that reported for the ligase-defective WWP2 (19). In con-
trast, the Nedd4 Cys mut had no effect on ClC-5 currents,
confirming that Nedd4 has no action on ClC-5 in oocytes. In-
terestingly, overexpression of wild type WWP2 was reported to
have no effect on ClC-5 currents in Xenopus oocytes (19). In the
current study, however, we observed a pronounced inhibition of
ClC-5 currents in the presence of wild type Nedd4-2 that in-
creased from 25 to 50% inhibition as the concentration of
Nedd4-2 cRNA was increased from 10 to 50 ng per oocyte.
Thus, the lack of effect of WWP2 on ClC-5 currents may be
simply due to the fact that a lower concentration of cRNA (5
ng/oocyte) was used in these experiments (19) or, alternatively,
that Nedd4-2 has a higher affinity thanWWP2 for ClC-5 in this
system. Importantly, the effect of Nedd4-2 on the whole-cell
currents was due to an actual reduction in the number of ClC-5
channels at the plasma membrane, highlighting the ability of
Nedd4-2 to regulate the cell surface availability of ClC-5.
Nedd4-2 induces the internalization of its target protein by
ubiquitination. ENaC is polyubiquitinated, leading to its re-
moval from the membrane and degradation in the lysosome
(34) and proteasome (52). An important finding of the current
study is that in response to albumin, ClC-5 is ubiquitinated. A
previous study investigating the interactions of WWP2 with
ClC-5 reported no success in demonstrating the ubiquitination
of ClC-5, an effect that was attributed to the possibility that the
ubiquitinated species may be short lived in a cellular system
(19). In support of this, we found that we could only detect the
significant levels of the ubiquitinated species induced by the
presence of albumin when the endocytic pathway is inhibited
by blocking the proteasome. Furthermore, preliminary in vitro
studies also suggest that ClC-5 is ubiquitinated.2 Our data
suggest the presence of a monoubiquitinated species of ClC-5;
however, due to the limitations of the methods, we cannot rule
out that ClC-5 is polyubiquitinated. Monoubiquitination is re-
garded as a signal for endocytosis (45, 53), resulting in the
trafficking of the target protein to multivesicular bodies and
subsequently the lysosome (46), or alternatively, the protein
may be deubiquitinated and returned to the recycling endo-
somes (54). We therefore demonstrate that albumin activates a
specific pathway that is not active in its absence. Inhibition of
the proteasome in control cells also increased surface levels of
ClC-5, although ClC-5 is not ubiquitinated under these condi-
tions. This can be explained by the known actions of proteaso-
mal inhibition in generally disrupting the endocytosis of mem-
brane proteins (54, 55). For example, inhibition of proteasome
was found to promote epidermal growth factor receptor recy-
cling and to block its degradation (46) and also to block the
normal trafficking of low density lipoprotein receptor-related
protein into the internal multivesicular bodies (45), with low
density lipoprotein receptor-related protein rapidly recycling
and accumulating at the cell surface. It is likely that such a
phenomenon also underlies the effects of MG132 on surface
levels of ClC-5 in OK cells not exposed to albumin.
The role of the proteasome in regulating levels of ClC-5
contrasts markedly with the findings for the sodium phosphate
transporter type II, where inhibition of the proteasome in OK
cells had no effect on the rates of parathyroid hormone-induced
degradation of this membrane transporter (56). In comparison,
both lysosmal and proteasomal inhibition have been shown to
regulate surface levels of ENaC (34, 52). The observation that
inhibition of both the proteasome and the lysosome has an
additive effect in reducing albumin uptake suggests that under
normal conditions, these pathways act in concert to degrade
various protein components of the endocytic complex. Albumin
uptake increases with the extracellular concentration of albu-
min within the physiological range (37). There must therefore
be a corresponding increase in the degradation of the proteins
involved. The fact that we observe a dramatic reversal in the
levels of total cellular ClC-5 and Nedd4-2 at a high (pathophys-
iological) concentration of albumin (1 mg/ml) presumably re-
flects a shutdown of this pathway due to depletion of key
components. The ubiquitin proteasome pathway also tightly
controls the levels of key regulatory molecules involved in a
myriad of cellular pathways, from cyclins to transcription fac-
tors through to ion channels, receptors, and endocytosis (57).
Thus, the reduced proteasomal activity and Nedd4-2 levels we
observe at higher pathophysiological levels of albumin may2 A. B. Fotia and S. Kumar, unpublished data.
FIG. 10. Model for ClC-5 and Nedd4-2 in constitutive albumin
uptake in OK cells. In the absence of albumin (left panel), ClC-5 exists
primarily in recycling endosomes with a minimal amount trafficking to
the plasma membrane. In the presence of albumin (right panel), a new
pathway is initiated with the endocytic complex forming (1). The total
cellular levels of ClC-5 increase in response to the need for more ClC-5
at the plasma membrane, and Nedd4-2 is recruited to the complex.
ClC-5 is ubiquitinated by Nedd4-2 (2) and removed from the membrane
into the albumin endocytic pathway (3). In addition, some ClC-5 may
recycle back to the endosome (?). The mechanisms that regulate the
base-line recycling and insertion of ClC-5 into the plasma membrane
remain to be elucidated.
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contribute in part to the tubular hypertrophy (58) typically
observed in diabetic renal disease, where reduced proteasomal
activity has also been reported (59).
Proteins containing PY motifs may interact with multiple
members of the Nedd4 family of ubiquitin ligases, yet each of
these ligases are themselves subject to specific regulation by
other proteins (24, 27, 60). Thus, it is critical to determine
which ubiquitin ligase is the true physiological regulator in a
given cell type. We therefore employed both dominant negative
mutant and silencing RNA strategies to determine that
Nedd4-2 had a role in constitutive albumin uptake in OK cells.
We found that only Nedd4-2 Cys mut was able to significantly
reduce albumin uptake, whereas Nedd4 Cys mut was without
effect, a result consistent with the effects of these mutants on
ClC-5 activity in oocytes. The physiological role of Nedd4-2 was
confirmed by the use of the siRNA plasmid directed against
Nedd4-2, which also inhibited albumin uptake. The specificity
of this effect was confirmed by the fact that in cells transfected
with the siRNA against Nedd4-2, endogenous Nedd4 levels
remained unchanged. The fact, however, that we do not observe
strong suppression of albumin uptake despite a 70% reduc-
tion in Nedd4-2 protein suggests either the involvement of an
intermediate protein or possibly that another ubiquitin ligase
(e.g. WWP2) can partially substitute for Nedd4-2. The data
from the current study are in agreement with the recent
findings of Snyder and co-workers, who used small silencing
RNA oligonucleotides to demonstrate that Nedd4-2 but not
Nedd4 was the physiological regulator of ENaC in two epi-
thelial cell lines (Fischer rat thyroid and H441) (23). More
recently, we have also shown that Nedd4-2 is the specific
ubiquitin ligase that acts on the voltage-gated Na channel,
Nav1.8 (26). The specific role of Nedd4-2 in albumin uptake is
further strengthened by our data showing a rapid increase in
protein levels of Nedd4-2 but not Nedd4 in response to albu-
min, which parallels the increase in ClC-5. Acute increases in
total Nedd4/Nedd4-2 protein levels in response to activation
of a cellular pathway have not previously been reported.
Given that the OK cells used in this study express both
Nedd4 and Nedd4-2, it is unclear why only Nedd4-2 is
specifically activated by albumin.
In conclusion, the current study identifies Nedd4-2 as a phys-
iological regulator of albumin uptake and further defines the
obligate role of ClC-5 in albumin uptake by the proximal tubule.
We present a new model for the regulation of albumin uptake
(Fig. 10). (i) In the absence of albumin, ClC-5 is located primarily
in recycling endosomes (14), similar to NHE3 (10), with some
present at the cell surface that is not ubiquitinated. (ii) The
presence of albumin triggers the formation of an endocytic com-
plex that includes ClC-5. (iii) Nedd4-2 is recruited to this complex
and ubiquitinates ClC-5. This ubiquitination by Nedd4-2 shunts
ClC-5 into the albumin uptake/degradative pathway. SomeClC-5
may recycle back to the plasma membrane pool. (iv) In response
to the increased requirement of these proteins, the cell produces
more ClC-5 and Nedd4-2. (v) The increase in membrane turn-
over/endocytosis and resultant degradation of albumin is accom-
panied by a significant increase in proteasomal activity. In this
case, the proteasome presumably plays a key role in maintaining
the integrity of the endocytic apparatus by regulating the levels
of specific components of this pathway. Our data show that, in
addition to its role in regulating Na reabsorption in the distal
tubules, Nedd4-2 plays a key role in mediating another constitu-
tive function of the kidney, namely albumin uptake by the prox-
imal tubule. It will be of interest to determine the extent to which
ubiquitination also regulates the levels of other membrane pro-
teins associated with the albumin uptake complex, such asNHE3
or megalin.
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